Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distribut…
- Recall date
- March 7, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0991-2019
- FDA classification
- Class III
- Brand / firm
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.
Get recall alerts
Free email alert whenever Boehringer Ingelheim Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Boehringer Ingelheim Pharmaceuticals, Inc.